UiPath, Inc. (PATH) › Analysis

UiPath, Inc. (PATH) stock analysis, September 9, 2026: PATH beat on profit, but fell 7.77% — is 13% growth the real story?

Published September 9, 2026 · PATH chart, levels and live analysis

Key Updates

UiPath (PATH) declined a further -5.96% since the September 4 report, closing at $14.01, extending the sharp reversal that has now fully unwound the multi-week rally referenced in prior updates (peak $18.22). The move was driven by the Q2 FY2027 10-Q filing (period ended July 31, 2026), which showed revenue of $410.3 million (+13% YoY) and net income of $36.1 million, a 2,178% increase YoY, with diluted EPS of $0.07 (SEC EDGAR). Despite the profitability beat, the stock fell -7.77% on the filing date, indicating the market focused on decelerating top-line growth rather than the bottom-line improvement.

Current Trend

PATH is down -14.52% YTD, having given back the entirety of its +18.13% six-month gain over the past week (-24.96% on a 5-day basis). The stock has broken below the $14.90 level that marked the prior report's price floor and is now testing levels last seen before the multi-week recovery began. The 1-month return of -6.91% masks the severity of the most recent leg down, confirming that the bulk of the damage has occurred in the last five trading sessions. No new support level has yet been established below $14.01; the next reference points are the pre-rally base near $15.50 (now resistance) and the $18.22 rally high, both of which are now well above the current price.

Investment Thesis

The core thesis for PATH rests on the company's transition from a high-growth, cash-burning automation vendor to a profitable enterprise software platform, supported by expanding adoption of agentic AI and RPA tools across large organizations. Sustained double-digit revenue growth combined with positive and improving net income is central to validating this transition and justifying a re-rating toward profitable SaaS peers.

Thesis Status

Q2 FY2027 results are directionally supportive of the profitability leg of the thesis: net income turned decisively positive with a 2,178% YoY increase and EPS of $0.07 (SEC EDGAR). However, the market's negative reaction to a headline earnings beat suggests that revenue growth of 13% YoY is being read as a deceleration signal, raising questions about the durability of the growth side of the thesis. The thesis is therefore only partially intact: the profitability narrative is strengthening, but the growth narrative is under pressure, and the stock's technical breakdown reflects this reassessment.

Key Drivers

The primary driver of the current move is the Q2 FY2027 10-Q filing, which delivered a substantial net income beat but only moderate revenue growth (SEC EDGAR). No PATH-specific strategic news (partnerships, product launches, guidance revisions) accompanied the filing. Adjacent industry developments — ViaPath's acquisition-driven expansion into corrections technology (PR Newswire) and Seeing Machines' launch of a Physical AI Platform for robotics (PR Newswire) — are unrelated to UiPath directly but illustrate continued capital deployment and platform expansion across the broader automation and AI ecosystem, a sector in which PATH competes.

Technical Analysis

PATH has broken down sharply, losing nearly 25% over five trading days and erasing the entire six-month uptrend. The -7.77% single-day drop on the earnings filing date confirms an accelerating downtrend with no clear support established at current levels. The prior report's price of $14.90 has failed as support, and the stock is now trading at its lowest level referenced across recent reports. The severity and speed of the decline (5d: -24.96%) indicate the stock is technically oversold in the near term, though momentum remains firmly negative and no reversal signal is evident in the data provided.

Bull Case

Bear Case

Get a message when the PATH picture changes — the agent team watches the levels and the news for you.Create a free account

More PATH analyses